Dyadic International Inc DE
Research Dyadic International Inc DE (DYAI) on Bullrun: market cap USD 16.03M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDYAI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 16.03M
- Financial periodQ2 2026
- RevenueUSD 123.89K
- Net income-USD 2.12M
- Free cash flow-USD 1.82M
- Gross margin-694.4%
Valuation Snapshot
latest market cap is USD 16.03M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.09M | -USD 7.36M | -USD 5.70M | 24.9% | -0.23 | USD 4.62M | USD 5.06M | USD 1.23M |
| FY2024 | USD 3.50M | -USD 5.81M | -USD 3.97M | 65.8% | -0.2 | USD 6.51M | USD 5.07M | USD 2.47M |
| FY2023 | USD 2.90M | -USD 6.80M | -USD 6.73M | 31.8% | -0.24 | USD 6.52M | USD 136.93K | USD 5.88M |
| FY2022 | USD 2.93M | -USD 9.74M | -USD 8.08M | 27.5% | -0.34 | USD 5.79M | USD 0 | USD 11.09M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 16.03M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 34.02M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 52.21M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 46.39M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 35.13M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 127.60M | n/a | n/a | n/a |
About Dyadic International Inc DE
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Dyadic International Inc DE's market cap?
Dyadic International Inc DE's market capitalization is USD 16.03M.
What does Dyadic International Inc DE do?
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins.